Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: Jan 01, 2016

Female Patients Require a Higher Propofol Infusion Rate for Sedation

DDS, PhD,
DDS, PhD,
DDS, PhD,
DDS,
DDS, PhD, and
DDS, PhD
Page Range: 67 – 70
DOI: 10.2344/0003-3006-63.2.67
Save
Download PDF

Sedation may minimize physiologic and behavioral stress responses. In our facility, the infusion rate of propofol is adjusted according to the bispectral index (BIS) in all cases of implant-related surgery; multivariate analysis of retrospective data enabled us to extract independent factors that affect the dose of propofol in sedation that are considered useful indicators for achieving adequate sedation. The study population comprised all patients undergoing implant-related surgery under intravenous sedation in Okayama University Hospital from April 2009 to March 2013. The infusion rate of propofol was adjusted to maintain the BIS value at 70–80. The outcome was the average infusion rate of propofol, and potential predictor variables were age, sex, body weight, treatment time, and amount of midazolam. Independent variables that affected the average infusion rate of propofol were extracted with multiple regression analysis. One hundred twenty-five subjects were enrolled. In the multiple regression analysis, female sex was shown to be significantly associated with a higher average infusion rate of propofol. Females may require a higher infusion rate of propofol than males to achieve adequate sedation while undergoing implant-related surgery.

  • Download PDF
<bold>Figure 1</bold>
Figure 1

Differences in average infusion rate of propofol by sex. Data are mean ± SD; n = 36 and 89 for male and female, respectively. * P < .01.


<bold>Figure 2</bold>
Figure 2

Differences in body weight by sex. Data are mean ± SD; n = 36 and 89 for male and female, respectively. * P < .01.


Contributor Notes

Address correspondence to Dr Shigeru Maeda, Department of Dental Anesthesiology, Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8525, Japan; maedas@md.okayama-u.ac.jp.
Received: Apr 15, 2015
Accepted: Jun 24, 2015